Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial

BACKGROUND: Elderly patients are particularly vulnerable to adverse drug reactions, especially if they are affected by additional risk factors such as multimorbidity, polypharmacy, impaired renal function and intake of drugs with high risk potential. Apart from these clinical parameters, drug safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Stingl, Julia Carolin, Kaumanns, Katharina Luise, Claus, Katrin, Lehmann, Marie-Louise, Kastenmüller, Kathrin, Bleckwenn, Markus, Hartmann, Gunther, Steffens, Michael, Wirtz, Dorothee, Leuchs, Ann-Kristin, Benda, Norbert, Meier, Florian, Schöffski, Oliver, Holdenrieder, Stefan, Coch, Christoph, Weckbecker, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845354/
https://www.ncbi.nlm.nih.gov/pubmed/27112273
http://dx.doi.org/10.1186/s12875-016-0447-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845354/
https://www.ncbi.nlm.nih.gov/pubmed/27112273
http://dx.doi.org/10.1186/s12875-016-0447-6

Ejemplares similares